The relative bioavailability of two formulations containing 10 mg Dapagliflozin assessed under fasting conditions in a randomized crossover study in healthy Caucasian subjects
, , , , , et
31 mars 2020
À propos de cet article
Publié en ligne: 31 mars 2020
Pages: 30 - 34
Reçu: 01 août 2019
Accepté: 29 janv. 2020
DOI: https://doi.org/10.2478/amma-2020-0006
Mots clés
© 2020 Monica Oroian et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Oroian, Monica
Department of Pharmaceutical Technology and Biopharmacy, Faculty of Pharmacy, University of Medicine and Pharmacy „Iuliu Haţieganu”Cluj-Napoca, Romania
Clinical Pharmacology and Pharmacokinetics DepartmentCluj-Napoca, Romania
Pop, Diana Ioana
Department of Pharmaceutical Technology and Biopharmacy, Faculty of Pharmacy, University of Medicine and Pharmacy „Iuliu Haţieganu”Cluj-Napoca, Romania
Clinical Pharmacology and Pharmacokinetics DepartmentCluj-Napoca, Romania
Gheldiu, Ana-Maria
Department of Pharmaceutical Botany, Faculty of Pharmacy, University of Medicine and Pharmacy „Iuliu Haţieganu”Cluj-Napoca, Romania
Bhardwaj, Sandeep
Clinical Pharmacology and Pharmacokinetics DepartmentCluj-Napoca, Romania
Marcovici, Adriana
Clinical Pharmacology and Pharmacokinetics DepartmentCluj-Napoca, Romania
Khuroo, Arshad
Clinical Pharmacology and Pharmacokinetics DepartmentGurugram, India
Vlase, Laurian
Department of Pharmaceutical Technology and Biopharmacy, Faculty of Pharmacy, University of Medicine and Pharmacy „Iuliu Haţieganu”Cluj-Napoca, Romania